Neurocrine Biosciences Inc (NBIX)

96.03 +1.72  +1.82% NASDAQ Apr 8, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
04/29/2020 16:30 EDT Misc Neurocrine Biosciences Inc First Quarter Earnings Conference Call in 2020
04/29/2020 Earnings Neurocrine Biosciences Inc First Quarter Earnings in 2020 Release
02/07/2020 Misc Neurocrine Biosciences Inc Annual Report for 2019
02/04/2020 16:30 EST Misc Neurocrine Biosciences Inc Fourth Quarter Earnings Conference Call for 2019
02/04/2020 Earnings Neurocrine Biosciences Inc Fourth Quarter Earnings in 2019 Release
11/04/2019 16:30 EST Misc Neurocrine Biosciences Inc Third Quarter Earnings Conference Call for 2019
11/04/2019 Earnings Neurocrine Biosciences Inc Third Quarter Earnings in 2019 Release
07/29/2019 16:30 EDT Misc Neurocrine Biosciences Inc Second Quarter Earnings Conference Call in 2019
07/29/2019 Earnings Neurocrine Biosciences Inc Second Quarter Earnings in 2019 Release
05/22/2019 Misc Neurocrine Biosciences Inc Annual General Meeting in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.neurocrine.com
  • Investor Relations URL: http://phoenix.corporate-ir.net/phoenix.zhtml?c=68817&p=irol-news&nyo=0
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Apr. 29, 2020
  • Last Earnings Release: Feb. 04, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Dec. 29, 1995
  • Description: Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Top Fund Holders

Symbol Name Weighting
PBE Invesco Dynamic Biotech & Genome ETF 5.38%
PBE Invesco Dynamic Biotech & Genome ETF 5.38%
DYN1651 Dynamic Power American Growth Series U 3.90%
FBT First Trust NYSE Arca Biotech ETF 3.35%
FBT First Trust NYSE Arca Biotech ETF 3.35%
FIJYX Fidelity Advisor® Biotechnology Z 2.53%
JFNSX Janus Henderson Global Life Sciences S 1.95%
JCNRX Janus Henderson Contrarian R 1.92%
XBI SPDR® S&P Biotech ETF 1.81%
XBI SPDR® S&P Biotech ETF 1.81%
FBIOX Fidelity® Select Biotechnology 1.56%
HQH Tekla Healthcare Investors 1.20%
IBB iShares Nasdaq Biotechnology ETF 1.17%
IBB iShares Nasdaq Biotechnology ETF 1.17%
VISGX Vanguard Small Cap Growth Index Inv 0.54%
VBK Vanguard Small-Cap Growth ETF 0.54%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.